Josh Weiner
Our perspective on obesity has evolved significantly, necessitating a corresponding shift in weight management strategies. Semaglutide-containing medications such as Ozempic and Wegovy are emerging as vital tools in combating obesity. However, according to Kyle Tan, co-founder of NOVI Health, these medications should be integrated into a broader strategy that includes diet, exercise, and behavioral support.
Traditional advice advocating for reduced food intake and increased physical activity often leaves individuals feeling demoralized, perceived as a personal failure to exhibit sufficient willpower. Yet, recent insights suggest obesity is more complex, influenced by factors beyond individual control such as genetics, mental health, and even certain medications. This realization challenges the simplistic view of obesity as merely a matter of self-discipline.
With obesity rates climbing, particularly among Singapore’s youth, it’s clear that a more nuanced approach is needed. Obesity, characterized by a BMI of 30 or higher (or 27.5 for Asians due to higher associated health risks), has far-reaching implications, including increased risk of heart disease, diabetes, and joint pressure.
Effective management of obesity requires addressing its root causes through a comprehensive approach. Quick fixes, such as dietary supplements or cosmetic procedures, offer only temporary solutions. In contrast, a holistic approach considers individual needs and factors, moving beyond superficial changes.
The medical field has seen exciting developments with new weight loss medications offering promising results. Semaglutide, for instance, has been linked to significant weight loss and calorie intake reduction in studies. Similarly, tirzepatide-containing Zepbound has shown potential weight loss comparable to bariatric surgery. Singapore’s Health Sciences Authority has approved several of these medications, marking a significant advancement in obesity treatment that not only aids in weight reduction but also mitigates the risk of associated chronic diseases.
Despite their benefits, these medications can have side effects, including gastrointestinal issues and potential risks of pancreatitis and gallbladder problems. Moreover, there’s a stigma surrounding the use of weight loss drugs, rooted in the outdated notion that weight loss should be achieved through willpower alone. Yet, as our understanding of obesity deepens, it’s clear that a multifaceted approach is necessary for effective and sustainable weight management.
What should individuals with obesity do? A balanced approach that combines medication, dietary adjustments, and physical activity, guided by professional advice, is key. Relying solely on diet or exercise may lead to muscle and bone loss, underscoring the need for a personalized plan that addresses the unique challenges of each individual.
As obesity continues to rise both in Singapore and globally, so too does our understanding of this complex disease and the treatment options available. This evolving knowledge offers hope for more effective control and management of obesity, emphasizing the importance of a comprehensive and tailored approach to weight loss.
